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We have cloned hTid-1, a human homolog of the Drosophila tumor suppressor protein Tid56, by virtue of its ability to form
complexes with the human papillomavirus E7 oncoprotein. The carboxyl terminal cysteine-rich metal binding domain of E7
is the major determinant for interaction with hTid-1. The carboxyl terminus of E7 is essential for the functional and structural
integrity of E7 and has previously been shown to function as a multimerization domain. The hTid-1 protein is a member of
the DnaJ-family of chaperones. Its mRNA is widely expressed in human tissues, including the HPV-18-positive cervical
carcinoma cell line HeLa and human genital keratinocytes, the normal host cells of the HPVs. The hTid-1 gene has been
mapped to the short arm of chromosome 16. The large tumor antigens of polyomaviruses encode functional J-domains that
are important for viral replication as well as cellular transformation. The ability of HPV E7 to interact with a cellular DnaJ
protein suggests that these two viral oncoproteins may target common regulatory pathways through J-domains. © 1998
Academic Press
INTRODUCTION
Expression of the E7 open reading frame is consis-
tently retained in human papillomavirus (HPV)-positive
cervical cancers (reviewed in zur Hausen, 1996). HPV-16
E7 encodes an acidic phosphoprotein of 98 amino acid
residues. The transforming activities of E7 are related, at
least in part, to its ability to interact with host cellular
proteins, including the retinoblastoma tumor suppressor
protein pRB and the related ‘‘pocket proteins’’ p107 and
p130. While binding of E7 to pRB is important for cellular
transformation, there are E7 mutants that can bind to
pRB but are transformation deficient (reviewed by Jones
and Mu¨nger, 1996). Moreover, in the background of the
full-length cloned HPV-16 genome, pRB-binding-deficient
mutants of E7 can contribute to immortalization of human
foreskin keratinocytes (Jewers et al., 1992). In addition,
although the E7 protein of the cottontail rabbit papillo-
mavirus (CRPV) is necessary for the virus-mediated in-
duction of warts in rabbits, transduction of CRPV ge-
nomes containing pRB-binding deficient mutants of E7
can still induce warts in rabbits (Defeo-Jones et al., 1993).
Hence, there is increasing evidence that E7 has cellular
targets in addition to the pocket proteins.
Several studies have been performed to identify cel-
lular proteins that have the capacity to interact with E7.
Such proteins include cyclin A (Dyson et al., 1992; Arroyo
et al., 1993; Tommasino et al., 1993) and cyclin E (McIn-
tyre et al., 1996), the cyclin-dependent kinase inhibitors
p21cip1 (Funk et al., 1997; Jones et al., 1997a) and p27kip1
(Zerfass-Thome et al., 1996), members of the AP-1 family
of transcription factors (Antinore et al., 1996), the TATA-
binding protein TBP (Massimi et al., 1996; Phillips and
Vousden, 1997), TAF110 (Mazzarelli et al., 1995), and
most recently, the S4 subunit of the 26S proteasome
(Berezutskaya and Bagchi, 1997). Here we report the
cloning of hTid-1, a human homolog of the Drosophila
tumor suppressor protein Tid56 (Kurzik-Dumke et al.,
1995), by virtue of its ability to interact with the HPV-16 E7
oncoprotein. Both Tid56 and hTid-1 contain J-domains,
as well as other conserved regions that are found in
some DnaJ proteins. DnaJ proteins interact with and
stimulate the ATPase activity of hsc70 family members
(Liberek et al., 1991; Palleros et al., 1993). These proteins
not only play a role in mediating the cellular response to
heat shock, but they also participate in many important
aspects of the metabolism of cellular proteins (reviewed
by Silver and Way, 1993), including protein folding (Geth-
ing and Sambrook, 1992; Georgopoulos and Welch,
1993), translocation across membranes (Brodski, 1996),
assembly and rearrangement of multiprotein complexes
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(Cyr et al., 1994), and protein degradation (Lee et al.,
1996). Recently it has been appreciated that the J-do-
main-related sequence that was detected in the amino
terminal domain of the large tumor antigens of many
polyomaviruses including SV40 (Cheetham et al., 1992;
Kelley and Landry, 1994) functions as an authentic J-
domain (Kelley and Georgopoulos, 1997) and plays im-
portant roles in viral replication and transformation
(Campbell et al., 1997; Srinivasan et al., 1997). Several
studies have indicated that the J-domain of polyomavirus
TAgs, in addition to the pRB-core binding site (LXCXE), is
necessary for targeting E2F/pocket protein transcrip-
tional repressor complexes (Sheng et al., 1997; Stubdal
et al., 1997; Harris et al., 1998; Zalvide et al., 1998). Other
viral oncoproteins, including adenovirus (Ad) E1A and
the HPV E7 oncoprotein, which also target these tran-
scription factor complexes, exhibit no homology to J-
domains. Interestingly, however, ectopic expression of
an isolated J-domain decreased SV40 TAg as well as
HPV-16 E7-mediated transcriptional activation of an E2F-
dependent reporter plasmid. In contrast, no consistent
effect was observed on Ad E1A-mediated activation of
this reporter (Sheng et al., 1997). These results suggest
that not all pRB-binding viral oncoproteins depend on a
J-domain to target E2F/pocket protein complexes. How-
ever, some viral oncoproteins whose sequences do not
contain a J-domain, such as HPV-16 E7, may recruit
cellular DnaJ proteins. The cloning of a novel, human
DnaJ protein that can interact with the carboxyl terminal,
cysteine-rich domain of HPV-16 E7 is consistent with this
model. Since the carboxyl terminus of E7 is necessary for
the structural and functional integrity of the E7 protein
(Phelps et al., 1992; McIntyre et al., 1993), it also sug-
gests that interactions of E7 with cellular J-domain pro-
teins may be significant for the biological activity of E7.
RESULTS
The HPV E7 oncoprotein can interact with a cellular
J-domain containing protein
To identify potentially novel cellular targets of the
HPV -16 E7 protein, we performed a yeast two-hybrid
screen. The full-length coding sequence of HPV-16 E7
fused to the DNA-binding domain of gal4 protein
(gal4DBD-E7) was used as a bait. Expression of the
gal4DBD-E7 bait was ascertained by immunoblot ex-
periments using both HPV-16 E7 and gal4-specific
antibodies (data not shown). We and others had pre-
viously recognized that when fused to a DNA-binding
domain, E7 can strongly activate transcription in yeast
(Clemens et al., 1995; Zwerschke et al., 1996). To
circumvent the problem of reporter gene activation by
the DNA-binding E7 bait alone, we used a modified
version of the two-hybrid system. In this implementa-
tion, each of the two hybrid proteins is expressed from
a low copy number plasmid. In addition, there are
three reporters, lacZ, URA3, and HIS3, that are each
integrated into the yeast genome. They have unique
core promoters to further decrease the number of false
positive colonies (Vidal et al., 1996; Vidal, 1997). The
inhibitor 3-aminotriazol (3-AT) can be used with the
HIS3 reporter to virtually eliminate the effect of bait
transactivation. The transcriptional activity of the
gal4DBD-E7 bait was manifested by the ability of these
yeast colonies to grow on histidine-deficient plates
containing up to 50 mM 3-AT. At a concentration of 60
mM 3-AT, however, growth of gal4DBD-E7-containing
yeast was inhibited, in contrast to yeast coexpressing
the E7 bait and either a pRB prey (amino acid residues
371–928) or an E7 prey (amino acid residues 2–98),
which continued to grow under these conditions (data
not shown). A previous study performed with a differ-
ent version of the two-hybrid system had shown that
these protein pairs could strongly interact (Clemens et
al., 1995). Therefore, we used a concentration of 60
mM 3-AT to perform the interaction screen with an
oligo (dT)-primed cDNA library from activated human
T-cells (Sardet et al., 1995). Interactions were scored
positive when both of the reporter genes, HIS3 and
lacZ, were expressed. Hence, positive colonies could
grow on histidine-deficient plates in the presence of at
least 60 mM 3-AT and turned blue when supplied with
chromogenic substrate X-gal. A total of 121 positive
clones were analyzed by dideoxy sequencing. This
screen yielded a clone containing the carboxyl termi-
nus of the pRB-related protein p130 (amino acids 479–
1024), further increasing our confidence in the validity
of this screen. The most frequently isolated known
protein was the highly basic, 40S ribosomal protein
S25 (12 clones). The second most frequently isolated
interactor (9 clones) represented a novel human DnaJ
protein. Two independent classes of clones were iso-
lated, a longer isolate that was identified six times and
a shorter clone that was identified three times. While
either clone showed strong amino-terminal homology
to a variety of DnaJ proteins, neither of these isolates
encoded a complete J-domain (Fig. 1).
In order to isolate a full-length clone of this protein, we
screened a lgt11 cDNA library constructed from the
HPV-positive cervical carcinoma cell line HeLa. The
longest clone isolated from this library had an insert size
of 2670 bp and encoded a putative protein of 480 amino
acids. Since no in-frame stop codon was detected up-
stream of the putative methionine initiation codon, we
attempted to isolate clones that contain additional 59
sequences. We performed multiple rounds of 59 RACE
(rapid amplification of cDNA ends) and screened this
and other cDNA libraries by PCR using combinations of
clone- and library-specific primer pairs. We were unable,
however, to identify cDNA clones that contained addi-
tional 59 sequences. Hence, we surmised that we iden-
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tified a cDNA clone containing the full-length coding
sequence of this gene (Fig. 1A).
The novel human J-domain protein is a homolog of
the Drosophila tumor suppressor protein Tid56
Similarity searches of this novel human DnaJ protein
showed that it exhibits a high degree of sequence iden-
tity over the entire coding sequence of the Drosophila
protein Tid56 (Kurzik-Dumke et al., 1995) (Fig. 1B). There-
fore we have named this protein hTid-1 (human homolog
of Drosophila Tid56). The gene encoding the Tid56 pro-
tein was identified as a gene that is not expressed in the
Drosophila mutant lethal(2)tumorous imaginal discs
(l(2)tid ). Failure to express Tid56 is manifested by an
embryonic lethal defect, tumorous imaginal discs (Kur-
zik-Dumke et al., 1992; 1995). Imaginal discs are clusters
of polarized epithelial cells which during pupation differ-
entiate to give rise to adult structures such as the legs,
wings, and eyes. In l(2)tid mutants the imaginal discs fail
to differentiate, continue to proliferate, and form lethal
tumors which maintain their neoplastic characteristics
when transplanted into wild-type flies (Kurzik-Dumke et
al., 1992).
The J-domain of hTid-1 shows sequence similarity to
many other DnaJ proteins including SV40 TAg (Fig. 1C). In
addition to the J-domain, Tid56 and hTid-1 each contain
additional hallmarks of some J-domain proteins including
a glycine/phenylalanine rich domain and a cysteine-rich,
metal binding domain (Fig. 1D).
hTid-1 binds to the carboxyl terminus of E7
In order to analyze the interaction of E7 with hTid-1 by
a method other than the yeast two-hybrid system we
employed an in vitro binding assay using bacterial-de-
rived fusion proteins of HPV-16 E7 to glutathione-S-trans-
ferase (GST-16 E7) and [35S]methionine-labeled hTid-1
produced by in vitro transcription/translation. As shown
in Fig. 2A, approximately 5% of the input hTid-1 protein
(lane 1) bound to GST-16 E7 (compare lanes 3 and 1). To
determine the sequences of E7 required for binding site
to hTid-1 we performed additional binding experiments
with domains of E7 fused to GST. These experiments
showed that the carboxyl terminus of HPV-16 E7 (lane 5)
was sufficient to interact with hTid-1 in vitro, albeit at a
somewhat reduced level when compared to the full-
length protein. The binding of hTid-1 to the amino-termi-
nal domain of E7, which contains the core pRB-binding
site (lane 4), was not above background levels (lane 2).
These results indicate that the carboxyl terminus of
HPV-16 E7 is sufficient for the interaction with hTid-1;
however, amino-terminal sequences of E7 may stabilize
the interaction.
To further map sequences in the carboxyl terminal
domain of HPV-16 E7 that contribute to binding of HPV-16
E7, we performed additional in vitro mixing experiments
(Fig. 2B). Mutations in the carboxyl terminus of E7 (GST-
E7 D91–94, GST-E7 D78–85, GST-E7 D52–57, GST-E7
C91S) resulted in reduced binding to hTid-1 (lanes 6, 7, 8,
9, compared to lane 1). Mutations in the second CXXC
motif (GST-16 E7 C91S, GST-16 E7 D91–94; Fig. 2B, lanes
6 and 9) appeared to affect binding to hTid-1 most sig-
nificantly. In contrast, deletions within the amino terminal
pRB binding domain or casein kinase II phosphorylation
site (GST-16E7 D21–24, GST-16E7 D35–37), did not impair
the binding of E7 to hTid-1 (Fig. 2B, lanes 5 and 4,
respectively).
We also found that the ‘‘low-risk’’ HPV-6 E7 protein can
interact with hTid-1, albeit with a lower efficiency than
HPV-16 E7 (compare Fig. 2B, lanes 3 and 1). Since the
CXXC motifs in the carboxyl terminus of E7 exhibit some
sequence similarity to the papillomavirus E6 oncopro-
tein, we tested whether hTid-1 could also interact with
HPV-16 E6. We only detected low-level binding of hTid-1
FIG. 1. Characterization of the hTid-1 clone. (A) Schematic representation of the 2670-bp hTid-1 clone isolated from the HeLa cDNA library. The
shaded bar represents the coding sequence of hTid-1. It is demarcated by putative initiation methionine residues at 32 bp and a stop codon at 1471
bp. The locations of a representative set of restriction endonuclease cleavage sites are shown for reference. (B) Amino acid sequence of hTid-1 and
comparison with the Drosophila Tid56 protein. Identical amino acid residues are marked by shaded boxes. The starting point of the two clones
identified by the initial yeast two-hybrid screen is indicated by arrowheads. The coding sequence of a putative spliced version of hTid-1 predicted
from comparisons with expressed sequence tags (ESTs, see Fig. 5A) that changes the coding sequence in the carboxyl terminus is also shown. (C)
Amino acid sequence comparison of the J-domains of hTid-1, Drosophila Tid56, E.coli dnaJ, the human dnaJ proteins hsp40/hdj-1, HSDJ/hdj-2, hsj-1,
and the J-domain in SV40 TAg. Identical residues are highlighted by the shaded boxes. Comparison was performed by visual inspection. (D)
Comparison of amino acid sequence identity in the amino terminus, J-domain (J), glycine/phenylalanine-rich (G/F), cysteine-rich (CXXC), and carboxyl
terminal domains of hTid-1 and Tid56.
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FIG. 1—Continued
to HPV-16 E6 protein fused to GST (Fig. 2B, lane 2). This
amount of binding was not significantly above back-
ground for GST alone.
Two domains of hTid-1 contribute to binding of
HPV-16 E7
In order to map the domains of hTid-1 that contribute
to E7 binding, we analyzed the binding of a series of
mutant hTid-1 polypeptides synthesized by in vitro tran-
scription/translation for binding to GST-E7 fusion pro-
teins. Each of the [35S]methionine-labeled hTid-1
polypeptides was incubated with either GST or GST
fused to the amino terminus (GST-16 E7 (2–36)), carboxyl
terminus (GST-16 E7(37–98)), or full-length HPV-16 E7
(GST-16 E7). Binding was scored as positive when it was
significantly above background for both full-length E7
and the carboxyl terminal domain of E7 in multiple ex-
periments. A representative set of results is presented in
Fig. 3. Although approximately equal amounts of input
proteins were used in these experiments, the results
shown are not strictly quantitative and no direct compar-
isons should be made between individual panels. Sur-
prisingly, both the amino terminal and the carboxyl ter-
minal halves of hTid-1 (1–235 and 236–480, respectively)
were found to be able to independently interact with E7
in vitro, indicating the presence of at least two binding
sites for E7 on hTid-1. Within the amino terminal binding
domain of hTid-1, neither half of this region (1–137 or
137–235) was found to be able to bind to E7. The critical
determinant of the carboxyl terminal binding domain was
mapped to amino acids 297–480, outside of the CXXC
domain. Within this domain of hTid-1, amino acid resi-
dues 297 to 342 contributed significantly to E7 binding
since a carboxyl terminal fragment consisting of hTid-1
amino acid residues 342–480 was no longer able to
interact with E7. These results do not rule out, however,
that the minimal E7 binding site on hTid-1 extends be-
yond this domain. We also tested whether the J-domain
contributed to the interaction with E7. We constructed a
mutant of hTid-1, where the critical histidine residue
within the J-domain (Tsai and Douglas, 1996) was mu-
tated to a glutamine residue (hTid-1 H121Q). This mutant
was able to interact with E7 as efficiently as the wild-type
protein. These results suggest that the interaction of
hTid-1 and E7 is not dependent upon a functional J-
domain. This is consistent with the finding that neither of
the hTid-1 clones that were isolated during the initial
yeast two-hybrid screen contained a full-length J-domain.
Interaction of HPV-16 E7 and hTid-1 in mammalian
cells
To document the ability of hTid-1 to interact with
HPV-16 E7 in mammalian cells we used a mammalian
version of the two-hybrid system (Fearon et al., 1992).
U2OS cells were transiently transfected with a reporter
plasmid containing the luciferase gene under the control
of five copies of gal4 binding sites. HPV E7 and hTid-1
were supplied as fusions with the gal4 DNA binding
domain and the activation domain of VP16, respectively.
Expression of the two chimeric proteins in U2OS cells
was verified by immunoblot analysis (data not shown).
As demonstrated in Fig. 4, cotransfection of gal4DBD-E7
and hTid-1-VP16 results in an almost 10-fold stimulation
of luciferase activity, compared to transfection of either
gal4DBD-E7 or hTid-1-VP16 alone. Control transfections
of the gal4 DNA binding domain (gal4DBD) and the VP16
activation domain (VP16AD) resulted in a less than 2-fold
stimulation of luciferase activity (Fig. 4).
hTid-1 mRNA is broadly expressed in different cell
types
In order to determine the expression pattern of
hTid-1 in different tissues, a multitissue Northern blot
(Clontech) was hybridized with a 32P-labeled hTid-1
probe. A human b-actin probe was used to evaluate
FIG. 2. The carboxyl terminus of E7 is sufficient for interaction with hTid-1. (A) In vitro mixing of 35S-labeled hTid-1 generated by in vitro
transcription/translation and bacterially expressed purified glutathione-S-transferase (lane 2) and fusions with the full-length E7 protein (lane 3), the
amino terminal half (lane 4), and the carboxyl terminal domain of E7 (lane 5). A sample corresponding to 10% of the input hTid-1 protein is shown in
lane 1. (B) In vitro mixing of 35S-labeled hTid-1 generated by in vitro transcription/translation and bacterially expressed purified GST fusions with
HPV-16 E7 (lane 1), HPV-16 E6 (lane 2) HPV-6 E7 (lane 3), and a series of mutations in the background of HPV-16 E7 (lanes 4 to 9). The amount of
hTid-1 bound to HPV-16 E7 corresponds to approximately 5% of the input.
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total mRNA levels in each lane. The highest level of
expression was detected in heart, liver, and skeletal
muscle (Fig. 5). We also documented expression of
hTid-1 mRNA in human foreskin keratinocytes, the
normal host cell type of the human papillomaviruses.
Furthermore, the full-length hTid-1 clone was isolated
from a cDNA library from the HPV-positive cervical
carcinoma cell line HeLa. A single major band of
approximately 2.7 kb was detected in each of the
tissues as well as in human foreskin keratinocytes
(Fig. 5). Keratinocyte mRNA was not included on the
original multitissue Northern blot and the panel repre-
sents an independent experiment. Therefore, the
abundance of hTid-1 mRNA in keratinocytes cannot be
directly compared to the other tissues. Since an alter-
natively spliced version in the carboxyl terminus only
leads to a deletion of 119 nucleotides, it may not be
resolved by this Northern blot procedure. The esti-
mated size of the mRNA (2.7 kb) is in good agreement
with the size of the cDNA clone (2.670 kb) that we have
isolated. A very faint band of less than 1.4 kb is also
detected in each lane. The identity of this mRNA spe-
cies is unknown.
hTid-1 maps to human chromosome 16
Comparison of hTid-1 sequence with the human
expressed sequence tag (EST) database showed that
there were at least 28 high-probability matches (E
values , 7 3 1028, Fig. 6A). Interestingly, several of
the clones show possible signs of alternative splic-
ing. Two of these putative splice products are located
in the 39 untranslated region, but one is located in
the carboxyl terminal region of hTid-1. Three differ-
ent EST clones were found to potentially encode
the same alternatively spliced version of hTid-1. Such
a splice event would result in a different carboxyl
terminus of hTid-1, where amino acid residues 447 to
480 are replaced by the sequence KRSTGN. The ex-
pression of alternatively spliced versions of hTid-1 is
currently being evaluated. Since the chromosomal
mapping of one of the ESTs (Human DRES 3 mRNA
sequence; Accession No.U69177) that corresponds
to hTid-1 (E value 5 0) has been determined, we
may conclude that the hTid-1 gene is located on chro-
mosome 16p13.3 between D16S3070 and D16S510
(Fig. 6B).
FIG. 3. Several regions of hTid-1 contribute to E7 binding. The indicated versions of hTid-1 were generated by in vitro transcription/translation and
mixed with GST, or fusions containing full-length HPV-16 E7 (GST-16 E7), the amino terminal domain (GST-16 E7 (2–36)) or the carboxyl terminal domain
(GST-16 E7 (37–98)) of HPV-16 E7. In some cases in vitro transcription/translation of hTid-1 fragments yielded multiple bands. These may reflect
internal initiations, premature terminations, or proteolytic cleavages. The starting points of the two clones identified by the initial yeast two-hybrid
screen at amino acid residues 116 and 141 are indicated.
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DISCUSSION
We have isolated a novel DnaJ protein, hTid-1, a human
homolog of the Drosophila tumor suppressor protein
Tid56, by means of its association with the HPV E7
protein. It was the second most frequently isolated clone
which scored positive with both the HIS3 and lacZ re-
porters. A total of nine clones representing two different
cDNA species were recovered. We were also able to
detect binding of hTid-1 to HPV-16 E7 by an in vitro
mixing assay. Therefore, it seems unlikely that this inter-
action is due to complex formation of an inappropriately
folded E7 fusion protein with a chaperone. Rather, it is
likely to reflect the ability of HPV-16 E7 to interact with a
DnaJ protein. We were unable to detect an interaction
between hTid-1 and HPV-16 E7 by immunoprecipitation/
immunoblot analyses. These attempts were hampered
by the observation that expression of hTid-1 interfered
with cellular viability, even in transient transfection as-
says. Therefore, we used a mammalian version of the
two-hybrid system (Fearon et al., 1992) to demonstrate
that an interaction between E7 and hTid-1 can be de-
tected in mammalian cells. The cloning of hTid-1 from a
cDNA library prepared from the HPV-18-positive cervical
carcinoma cell line HeLa demonstrates that HPV E7 and
hTid-1 mRNAs are coexpressed in HPV-positive cervical
cancer cells.
Our mapping experiments indicate that the carboxyl-
terminal, cysteine-rich domain of HPV-16 E7 repre-
sents the major interaction domain for hTid-1. This
region of the protein has previously been shown to be
necessary for the structural and functional integrity of
E7 (Phelps et al., 1992), contains a multimerization
domain (McIntyre et al., 1993; Clemens et al., 1995;
Zwerschke et al., 1996), and can function as a binding
site for several cellular proteins (Antinore et al., 1996;
Zerfass-Thome et al., 1996; Berezutskaya et al., 1997).
Although this domain is not necessary for interaction
of E7 with pRB in most assays (Patrick et al., 1994), the
carboxyl terminus of E7 is necessary for the physical
disruption of E2F/pRB complexes (Wu et al., 1993).
Polyomavirus large tumor antigens contain an amino
terminal J-domain, and the chaperone function is re-
quired for many of the biological activities of these
proteins (reviewed by Brodsky and Pipas, 1998). Inter-
estingly, in SV40 TAg, the J-domain, in addition to the
pRB binding site, is necessary for the disruption of
E2F/pocket protein complexes (Sheng et al., 1997;
Stubdal et al., 1997; Harris et al., 1998; Zalvide et al.,
1998). It is predicted that ectopic expression of an
isolated J-domain will interfere with viral oncoprotein-
mediated transcriptional activation of E2F, if this pro-
cess is J-domain dependent. Not surprisingly, J-do-
main expression interfered with SV40 TAg-dependent
activation of the reporter. This presumably reflects
competition for binding to hsc70, the functionally im-
portant interaction partner of the J-domain. Interest-
ingly, however, activation of an E2F-dependent re-
FIG. 5. Expression of hTid-1 mRNA in various human tissues and
cultured human foreskin keratinocytes by Northern blot analysis. A
human b-actin probe was used as a loading control. The size of the
major mRNA species was estimated to be approximately 2.7 kb, which
is in good agreement with the length of the hTid-1 cDNA clone pre-
sented here (2670 bp). A minor band of approximately 1.4 kb is also
detected. The panel showing hTid-1 expression in human foreskin
keratinocytes represents an independent experiment and the abun-
dance cannot be directly compared to the other tissues.
FIG. 4. Interaction of HPV-16 E7 and hTid-1 in a mammalian two-
hybrid system. See Materials and Methods for details. Activation by
gal4-DBD-E7 was set to one. The values are means and standard
deviations. A gal4-VP16 fusion protein activated over 200-fold in this
system.
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porter by HPV-16 E7, but not Ad E1A, was also reduced
upon ectopic expression of an isolated J-domain.
These results suggested that E7-mediated activation
of E2F complexes is also J-domain dependent (Sheng
et al., 1997). The HPV-16 E7 protein has no detectable
sequence similarity to a J-domain, but our results
FIG. 6. (A) Human expressed sequence tags (ESTs) corresponding to hTid-1. Only the highest scoring sequences are shown. The shaded areas
represent deletions present in these clones relative to the hTid-1 sequence presented here. Such deletions may represent alternative splicing events.
Note that U69177, Z19422, and W31089 have identical deletions. This deletion affects the coding sequence of hTid-1 in the carboxyl terminus. See text
and Fig. 1 for details. (B) hTid-1 is located on chromosome 16p13.3. The assignment was performed for IB1814, which corresponds to clone U69177
(DRES3), the longest and most similar EST.
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presented here show that E7 is able to interact with
hTid-1, a cellular DnaJ protein. It has been reported
that the amino terminal domain of pRB can interact
with hsc70 (Inoue et al., 1995). Therefore, a model has
been proposed that SV40 TAg may contact pRB both
directly through the LXCXE motif and indirectly through
an interaction via its J-domain, contacting the hsc70
protein bound to pRB (Sheng et al., 1997). Given the
dependence of E2F activation by HPV-16 E7 on a
J-domain, and the ability of HPV-16 E7 to interact with
a cellular DnaJ protein, hTid-1 (this study), it is possi-
ble that this model may be extended to the E7–pRB
interaction.
It has been recently reported that E7 can destabilize
pRB (Boyer et al., 1996; Jones and Mu¨nger, 1997) and that
sequences outside of the amino terminal core pRB-bind-
ing domain are necessary for this activity (Jones et al.,
1997b). Expression of SV40 TAg interferes with the ac-
cumulation of certain phosphorylated forms of p107 and
p130 (Stubdal et al., 1996), and the J-domain is important
for this activity (Stubdal et al., 1997). As an important
point of distinction, however, unlike HPV-16 E7, SV40 TAg
does not interfere with the phosphorylation status or the
stability of pRB (DeCaprio et al., 1989; Stubdal et al.,
1996). Since amino terminal sequences of E7 are neces-
sary for E7-mediated destabilization of pRB (Jones et al.,
1997b), and the hTid-1 binding site has been mapped to
the carboxyl terminus of E7, it appears unlikely that
hTid-1 directly contributes to E7-mediated pRB destabi-
lization. On the other hand, given that E7 mutants in the
carboxyl terminus often are unstable, we have been
unable to conclusively address whether carboxyl termi-
nal sequences also contribute to pRB destabilization
(Jones et al., 1997b).
It was mentioned in a recent review that a human
homolog of Tid56 was also cloned by a two-hybrid
screen with the armadillo repeats of the adenomatous
polyposis coli (APC) tumor suppressor protein as bait
(Polakis, 1997). Since the sequence of this homolog has
not been deposited with GenBank, it could not be com-
pared to hTid-1. Interestingly, it has recently been re-
ported that the HPV E6 protein can interact with a human
homolog of the Drosophila discs large tumor suppressor
protein (hDLG) (Kiyono et al., 1997; Lee et al., 1997),
which has also been shown to form complexes with APC
(Matsumine et al., 1996). Together these results may
suggest that by interacting with hDLG and the DnaJ
protein, hTid-1, both HPV E6 and E7 may target cellular
pathways that are controlled by the APC tumor suppres-
sor protein, leading to the abrogation of some functions
of APC during cervical carcinogenesis.
Only a limited number of human DnaJ proteins have
been isolated thus far. These include dj1 (hsp40/hdj-1;
Raabe and Manley, 1991; Ohtsuka, 1993), dj2 (HSDj/hdj-2;
Chellaiah et al., 1993; Oh et al., 1993), and hsj1
(Cheetham et al., 1992). The cloning of hTid-1 adds a new
member to the human DnaJ family of proteins. Given the
high degree of conservation between Drosophila Tid56
and human hTid-1, it is possible that the two proteins
may be involved in regulating similar cellular activities. In
Drosophila, failure to express Tid56 leads to the aberrant
cellular proliferation and failure of differentiation in the
imaginal discs (Kurzik-Dumke et al., 1992; 1995). Imagi-
nal discs consist of epithelial cells and although there is
no stratification in this polarized epithelium, this pheno-
type is somewhat reminiscent of the tumor phenotype
caused by aberrant expression of HPV oncoproteins. In
particular, it has been shown that expression of the
high-risk HPV E7 oncoprotein is sufficient to uncouple
cellular proliferation and differentiation in keratinocytes
(Blanton et al., 1992; Cheng et al., 1995; Jones et al.,
1997a). Therefore, it is tempting to speculate that hTid-1
might also be involved in regulating similar processes in
human cells. Although Tid56 has been classified as a
tumor suppressor protein in Drosophila (Kurzik-Dumke et
al., 1992; Gateff, 1994), there is no evidence that hTid-1
can act as a tumor suppressor in human cells. The
chromosomal localization of hTid on the short arm of
chromosome 16 is relatively close to the tuberous scle-
rosis gene 2 (TSC2) locus. A candidate gene that is
mutated in many patients has been cloned (The Euro-
pean Chromosome 16 Tuberous Sclerosis Consortium,
1993) and does not correspond to hTid-1. Nevertheless,
in the course of these experiments it was evident that
ectopic expression of hTid-1, even in transient assays,
interfered with cellular viability (data not shown). Once
we have generated the necessary tools, we will be able
to study whether this effect on cellular viability reflects
some of the normal biological functions of hTid-1.
MATERIALS AND METHODS
Yeast two-hybrid screen
A library of cDNAs prepared from activated human
T-cells fused to the gal4 activation domain was screened
using a modified version of the yeast two-hybrid system
(Vidal et al., 1996; Vidal, 1997). The full-length E7 gene
fused to the gal4 DNA binding domain was used as bait.
Yeast media were purchased in premixed form from
Bio101 Inc. (Vista, CA). Intrinsic transcriptional activation
of the E7 bait was overcome by using 3-aminotriazol
(3-AT; Sigma), an inhibitor of the HIS3 selection marker. A
concentration of 60 mM 3-AT was used for the screen.
Expression of the proteins was ascertained by standard
immunoblot assays using Immobilon P membranes (Mil-
lipore) as previously described. Antibodies recognizing
the gal4-DNA binding domain (kind gift from Dr. G. Gill,
Harvard Medical School, Boston, MA), HPV-16 E7 (#6981,
Santa Cruz), and pRB (MAb 245, Pharmingen) were used.
Secondary antibodies were purchased from Amersham
and enhanced chemiluminescence (ECL, Amersham)
was used for the detection of antigen/antibody com-
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plexes. Yeast colonies growing on 60 mM 3-AT-contain-
ing plates were rescreened for expression of lacZ, a
second independent reporter gene using X-gal. Only
colonies that scored positive by both criteria were clas-
sified as positive. Of the total of 1.5 x 106 yeast colonies
that were screened, 9 clones representing two indepen-
dent cDNAs corresponding to hTid-1 were identified. A
longer clone (initiating at amino acid 116) was identified
six times and a shorter clone (initiating at amino acid
141) was isolated three times. Neither of these clones
contains the entire J-domain.
Isolation of a full-length hTid-1 cDNA clone
The cDNA from the initial yeast two-hybrid screen was
used as a probe for the screening of a cDNA library
prepared from the human cervical carcinoma cell line
HeLa in lgt11 (kind gift of Dr. G. Gill, Harvard Medical
School, Boston, MA). The clone with the longest 59 end
was chosen for further sequence analysis. Since the
sequence upstream of the putative initiation methionine
residue does not contain an in-frame stop codon we
attempted to identify additional 59 sequences by 59 rapid
amplification of cDNA ends (59-RACE System, GIBCO-
BRL) or by PCR using a combination of hTid-1 and clon-
ing vector-specific primers with several other cDNA li-
braries as templates. We were unable to identify addi-
tional 59 sequence and surmise that our clone
represents a full-length or nearly full-length species.
Sequence analyses
A combination of manual and automated sequencing
was performed to determine the nucleic acid sequence
of the hTid-1 clone. On-line tools of the National Center
for Biotechnology information (NCBI,http://www.ncbi.
nlm.nih.gov/) were used to perform sequence similarity
searches (Altschul et al., 1997) as well as to determine
the chromosomal mapping. Protein alignments were per-
formed using the GCG suite of protein sequence analy-
sis tools unless stated otherwise.
Mammalian cell culture, transfections, and luciferase
assays
The human osteosarcoma cell line U2OS was grown in
Dulbecco’s modified Eagle’s Medium (DMEM, GIBCO/BRL)
supplemented with 10% fetal bovine serum. Transient trans-
fection assays were performed using the calcium phos-
phate procedure. Forty-eight hours posttransfection, cells
were harvested and processed for luciferase activity as-
says using a commercially available kit.
Plasmids and in vitro protein synthesis
A 2.8-kb fragment containing the full-length coding
sequence of hTid-1 as well as the 39 UTR was cloned
into the EcoRI sites of pGem-7Zf(1) to be used for in vitro
transcription/in vitro translation. Oligonucleotide-directed
mutagenesis of the conserved histidine residue to glu-
tamine (H121Q) was performed using the Quickchange
kit (Stratagene) according to the protocol supplied. Frag-
ments of hTid-1 were prepared by in vitro transcription/
translation of PCR products that were generated with 59
primers that, in addition to the hTid-1 sequence, con-
tained an in-frame methionine residue and a T7 promoter
sequence. Coupled in vitro transcription/translation re-
actions were performed in rabbit reticulocyte lysates
(TnT kit, Promega).
To express the gal4DBD-E7 fusion protein in mamma-
lian cells, E7 sequences (amino acids 2–98) were cloned
into pSG424 (Sadowski et al., 1988), which contains the
gal4 DNA binding domain (amino acids 1–147). The hTid-
1VP16 fusion was created by inserting hTid-1 sequences
(amino acids 88–480) into pCMVNLS-VP16 (a gift from Y.
Shi). The gal4-responsive plasmid pG5-luc was used as
a reporter (Haviv et al., 1995).
The construction, purification, and use of the various
GST E7 fusion proteins for in vitro mixing experiments
have been previously described (Wu et al., 1993).
RNA expression analysis
A multiple tissue mRNA blot was purchased and an-
alyzed according to the manufacturer’s protocols (Clon-
tech). Total cellular RNA was isolated from cultured hu-
man foreskin keratinocytes by the guanidine isothiocya-
nate method (Chirgwin et al., 1979) and separated on a
1% agarose gel containing 0.66 M formaldehyde in 20
mM Mops, 5 mM sodium acetate, and 1 mM EDTA, pH
7.9. Transfer to nylon membranes (Highbond-N; Amer-
sham) was according to the manufacturer’s recommen-
dations.
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